atopic dermatitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged 16 years or older at the time of obtaining informed consent. Patients diagnosed with atopic dermatitis. Patients with mild to moderate disease severity at the time of enrollment (Eczema Area and Severity Index (EASI) under 21).
Exclusion criteria
Exclusion criteria: 1) Patients with serious comorbid conditions, such as severe cardiac, hepatic, renal, pulmonary, or hematologic diseases, that are considered inappropriate for participation in this clinical study. 2) Patients with a current or prior history of malignant neoplasms. However, patients with a history of malignancy who are not receiving active treatment and have remained recurrence-free for at least five years at the time of obtaining informed consent will be eligible for inclusion. 3) Patients who have participated in another post-marketing clinical study within 120 days prior to enrollment (defined as the date of the last administration of an investigational or study drug), or who are currently participating in another clinical study or post-marketing clinical trial. 4) Patients who are otherwise deemed ineligible for participation in this clinical study by the principal investigator or study investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| DLQI (Dermatology Life Quality Index), Skindex16 | — |
Countries
Japan
Contacts
Keio University Department of dermatology